tiprankstipranks
Waters Corp. (WAT)
NYSE:WAT
US Market
Want to see WAT full AI Analyst Report?

Waters (WAT) Earnings Dates, Call Summary & Reports

439 Followers

Earnings Data

Report Date
Aug 04, 2026
Before Open (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
2.97
Last Year’s EPS
2.95
Same Quarter Last Year
Moderate Buy
Based on 16 Analysts Ratings

Earnings Call Summary

Q1 2026
Earnings Call Date:May 05, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call presents a predominantly positive picture: strong combined‑company Q1 results with double‑digit organic growth in legacy businesses, a meaningful EPS beat (+20%), margin outperformance, an above‑plan start for the acquired BD businesses, and raised full‑year guidance. Management also outlined concrete integration actions (180‑day plan), product/regulatory wins, and synergy targets with clear timelines. Offsetting risks include a $20M respiratory headwind, notable China DRG and export constraints that drove declines in parts of the acquired businesses, Q1 GAAP acquisition‑related charges and modest free cash flow impacted by transaction costs, and prudent conservatism baked into the back‑half guide. Overall the positives—beats, raised guidance, tangible synergy progress and product/regulatory milestones—materially outweigh the near‑term operational and geographic headwinds.
Company Guidance
Guidance: Waters raised full‑year 2026 organic constant‑currency revenue growth to 6.5%–8% (embedding $15M of mass‑spec cross‑sell revenue synergies), expects the acquired Biosciences and Diagnostic Solutions to generate ~ $3.035B of reported 2026 revenue (including $35M of revenue synergies), and sees total 2026 reported revenue of ~$6.405B–$6.455B; adjusted EPS guidance was nudged up $0.10 to $14.40–$14.60 (implying 10%–11% EPS growth), adjusted EBIT margin is expected to be 28.2% for 2026, net interest expense ~ $186M, and an ongoing tax rate of ~16%; near‑term targets include $55M of cost synergies in 2026 and ~$50M of revenue synergies this year (split into the $35M and $15M noted above). For Q2, Waters expects organic constant‑currency growth of 6%–8% (FX ≈ 0.5% headwind) -> organic reported revenue $814M–$829M, Biosciences & Diagnostic Solutions revenue ~ $802M, total reported Q2 revenue $1.616B–$1.631B, and Q2 adjusted EPS of $2.95–$3.05.
Strong Combined Revenue and Organic Growth
Total reported Q1 revenue $1.267B; organic revenue $747M and grew 13% as reported / 11% constant currency versus Q1 2025; orders outpaced sales.
Acquisition Performance Beat
Revenue from Biosciences and Diagnostic Solutions during owned period $520M, beating guidance by $40M; Biosciences: $230M (~7% estimated as‑reported growth); Diagnostic Solutions: $288M (~8% estimated as‑reported growth).
Adjusted EPS and Margin Outperformance
Adjusted EPS grew 20% year‑over‑year to $2.70, beating the high end of guidance by $0.35; adjusted gross margin 54.7% (~200 bps better than expected); adjusted operating margin 23.6% (~200 bps better than expected).
Raised Full‑Year Guidance
Organic constant currency revenue guidance raised to 6.5%–8% for 2026; total reported 2026 revenue now expected ~$6.405B–$6.455B; adjusted EPS guidance raised $0.10 to $14.40–$14.60 (10%–11% growth).
Synergy Progress and Targets on Track
On track to deliver $55M in cost synergies for 2026; targeting $50M in revenue synergies for 2026 with $35M expected contribution from acquired businesses; restructuring savings to start hitting P&L in Q3.
Commercial Execution and Early Revitalization (180‑day Plan)
Launched rapid 180‑day plan to increase forecast rigor, field activity and pricing discipline; increased call volumes and deal desk deployment; initial contract review in U.S. Diagnostics found ~700 out‑of‑compliance contracts (double‑digit million annual opportunity).
Product and Regulatory Milestones
BACTEC FXI blood culture system received CE marking (faster detection, 60-sample loading); FDA cleared BD Onclarity HPV self‑collection kit and assay; launched Microflow LC Chemistry Columns (up to 2x sensitivity) and omniDAWN detector—strengthening differentiation in bioseparations and light scattering.
Instrument Replacement and Service Upside
Identified ~22,000 instruments ripe for replacement (12,000 BACTEC; >50% >5 years old); service plan attachment initiatives expected to generate at least $20M incremental revenue over 5 years; accelerated BACTEC FXI U.S./EU launch by 3–5 months.

Waters (WAT) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

WAT Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 04, 2026
2026 (Q2)
2.96 / -
2.95
May 05, 2026
2026 (Q1)
2.31 / 2.70
2.2520.00% (+0.45)
Feb 09, 2026
2025 (Q4)
4.51 / 4.53
4.110.49% (+0.43)
Nov 04, 2025
2025 (Q3)
3.21 / 3.40
2.9316.04% (+0.47)
Aug 04, 2025
2025 (Q2)
2.94 / 2.95
2.6312.17% (+0.32)
May 06, 2025
2025 (Q1)
2.22 / 2.25
2.211.81% (+0.04)
Feb 12, 2025
2024 (Q4)
4.03 / 4.10
3.6213.26% (+0.48)
Nov 01, 2024
2024 (Q3)
2.68 / 2.93
2.843.17% (+0.09)
Jul 31, 2024
2024 (Q2)
2.57 / 2.63
2.8-6.07% (-0.17)
May 07, 2024
2024 (Q1)
2.09 / 2.21
2.49-11.24% (-0.28)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

WAT Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 09, 2026
$381.29$328.14-13.94%
Nov 04, 2025
$345.59$367.34+6.29%
Aug 04, 2025
$290.31$285.59-1.63%
May 06, 2025
$348.38$339.02-2.69%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Waters Corp. (WAT) report earnings?
Waters Corp. (WAT) is schdueled to report earning on Aug 04, 2026, Before Open (Confirmed).
    What is Waters Corp. (WAT) earnings time?
    Waters Corp. (WAT) earnings time is at Aug 04, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is WAT EPS forecast?
          WAT EPS forecast for the fiscal quarter 2026 (Q2) is 2.97.